Method and system for sustained-release of sclerosing agent

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 29/16 (2006.01) A61L 29/08 (2006.01) A61L 29/10 (2006.01) A61M 1/00 (2006.01) A61M 1/04 (2006.01) A61M 25/00 (2006.01) A61M 31/00 (2006.01)

Patent

CA 2703849

Methods and systems for treating pleural disease comprising a providing a low dosage of a sclerosing agent over a period of time. Certain examples include catheter with a sclerosing agent that is inserted into the pleural space. The sclerosing agent is released in a sustained-release manner over a period of time to achieve diffuse pleurodesis of the pleural layers.

L'invention concerne des procédés et des systèmes permettant de traiter une maladie pleurale par administration d'une faible dose d'agent sclérosant pendant une durée prédéterminée. Dans certains exemples, un cathéter contenant un agent sclérosant est inséré dans un espace pleural, puis l'agent sclérosant est libéré de manière contrôlée pendant une durée prédéterminée afin de d'obtenir une pleurodèse diffuse des couches pleurales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method and system for sustained-release of sclerosing agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and system for sustained-release of sclerosing agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and system for sustained-release of sclerosing agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1911599

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.